| Value | ₹433.2 Cr |
|---|
NSE filing, NSE: WAKEFIT. Summary written from the filing by ALFA Finder's alert engine.
Wakefit Innovations Ltd: key numbers
- Share price
- ₹135.03
- Market cap
- ₹4,478 Cr
- Revenue (annual)
- ₹1,489 Cr
- Net profit (annual)
- ₹189.2 Cr
- P/E (TTM)
- 23.2×Sector 33.4×
- Promoter holding
- 37.07%+0.19% QoQ
- FII holding
- 14.36%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Wakefit Innovations Ltd
All →Wakefit Innovations Other Announcement
Wakefit Innovations Ltd has submitted the quarterly certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the period ended September 30, 2026.
Wakefit Innovations Employee Stock Options
Wakefit Innovations Limited has granted 2,25,442 employee stock options under its ESOP-2019 plan. These options are exercisable into equity shares at a price of Rs. 1 each.
Wakefit Innovations Management Change
Mr. Kunal Chandel, Senior Manager - Legal and Senior Management Personnel, has resigned from Wakefit Innovations Limited, effective from the close of business on September 24, 2026.
Wakefit Innovations Annual General Meeting
Wakefit Innovations Limited held its 10th Annual General Meeting on September 09, 2026, through video conferencing to discuss and adopt financial matters.
Wakefit Innovations Employee Stock Options
Wakefit Innovations Limited has allotted 3,13,521 equity shares to employees following ESOP exercise. This increases the company's total paid-up equity share capital to 33,16,45,219 shares.
Wakefit Innovations Other Announcement
Wakefit Innovations Ltd is notifying shareholders with unregistered email addresses about how to access the Annual Report and AGM notice. This is a routine compliance communication.
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.